4.7 Article

Design of a True Bivalent Ligand with Picomolar Binding Affinity for a G Protein-Coupled Receptor Homodimer

期刊

JOURNAL OF MEDICINAL CHEMISTRY
卷 61, 期 20, 页码 9335-9346

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.8b01249

关键词

-

资金

  1. Spanish Ministerio de Economia, Inchistria y Competitividad [SAF2014-60138-R, SAF2014-54840-R, SAF2016-77830-R, SAF2015-74627-JIN]
  2. CIBER-BBN [CB06-01-0074]
  3. CIBERNED [CB06/05/0064]
  4. Generalitat de Catalunya [2014SGR137, 2014SGR1236, 2017SGR1439, 2017SGR1497]
  5. Fundacio La Marato de TV3 [20140610]
  6. National Institute on Drug Abuse

向作者/读者索取更多资源

Bivalent ligands have emerged as chemical tools to study G protein-coupled receptor dimers. Using a combination of computational, chemical, and biochemical tools, here we describe the design of bivalent ligand 13 with high affinity (K-DB1( )= 21 pM) for the dopamine D-2 receptor (D2R) homodimer. Bivalent ligand 13 enhances the binding affinity relative to monovalent compound 15 by 37-fold, indicating simultaneous binding at both protomers. Using synthetic peptides with amino acid sequences of transmembrane (TM) domains of D2R, we provide evidence that TM6 forms the interface of the homodimer. Notably, the disturber peptide TAT-TM6 decreased the binding of bivalent ligand 13 by 52-fold and had no effect on monovalent compound 15, confirming the D2R homodimer through TM6 ex vivo. In conclusion, by using a versatile multivalent chemical platform, we have developed a precise strategy to generate a true bivalent ligand that simultaneously targets both orthosteric sites of the D2R homodimer.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据